Drug profile · INN
dapagliflozin
FORXIGA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dapagliflozin (FORXIGA) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN dapagliflozin
Brand FORXIGA
Route ORAL
Formulation TABLET, EXTENDED RELEASE
ATC code A10BK01
Originator AstraZeneca
Frequently asked questions
What is dapagliflozin?
dapagliflozin (FORXIGA) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dapagliflozin?
FORXIGA is a marketed brand name for dapagliflozin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dapagliflozin?
dapagliflozin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.